OrthoTrophix, Inc.

May 12, 2025

OrthoTrophix Initiated Phase 2b Clinical Trial of TPX-100 in Patients with Mild to Severe Knee Osteoarthritis

May 12, 2020

TPX-100: OrthoTrophix Presents More Evidence for Disease Modification in Knee Osteoarthritis in a New Abstract Published in Osteoarthritis & Cartilage Journal

Mar 02, 2020

TPX-100: OrthoTrophix Demonstrates Evidence for Disease Modification in Knee Osteoarthritis

Mar 02, 2020

TPX-100: OrthoTrophix Demonstrates Evidence for Disease Modification in Knee Osteoarthritis

May 13, 2019

TPX-100 Delays Pathological Changes of Bone in Osteoarthritis of the Knee

Oct 23, 2018

OrthoTrophix Presents Knee Cartilage Structure Modification Data of TPX-100 at American College of Rheumatology Annual Meeting

Oct 11, 2018

OrthoTrophix Will Present Clinical Outcome of a TPX-100 Study Including Knee Cartilage Structure Modification Data at Annual Meeting of American College of Rheumatology 2018

Aug 13, 2018

Clinical Benefits of TPX-100 in Knee Osteoarthritis Patients are Associated with Improvements in Knee Cartilage Structure Modification

Apr 17, 2018

OrthoTrophix Will Present Data on Long-Term Clinical Benefit of TPX-100 in Mild to Severe Knee Osteoarthritis Patients at OARSI Annual Meeting 2018

Nov 07, 2017

OrthoTrophix Presents the Key Data of the TPX-100 Phase 2 Study as a Late Breaking Abstract at American College of Rheumatology Annual Meeting